MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.heliyon.2024.e33679

Медицинская библиотека · Heliyon · 2024

Pneumomediastinum and pneumothorax in coronavirus disease-2019: Description of a case series and a matched cohort study.

Tekin Aysun, Devarajan Anusha, Sakata Kenneth K, Qamar Shahraz, Sharma Mayank, Valencia Morales Diana J, Malinchoc Michael, Talaei Fahimeh, Welle Stephanie, Taji Jamil, Khosa Sandeep, Sharma Nikhil, Brown Meghan, Lal Amos, Bansal Vikas, Khan Syed Anjum, La Nou Abigail T, Sanghavi Devang, Cartin-Ceba Rodrigo, Kashyap Rahul, Gajic Ognjen, Domecq Juan P, Azadeh Natalya

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To describe the characteristics of COVID-19 patients with pneumothorax and pneumomediastinum (PTX/PM) and their association with patient outcomes.

PATIENTS AND

METHODS

Adults admitted to five Mayo Clinic hospitals with COVID-19 between 03/2020-01/2022 were evaluated. PTX/PM was defined by imaging. Descriptive analyses and a matched (age, sex, admission month, COVID-19 severity) cohort comparison was performed. Hospital mortality, length of stay (LOS), and predisposing factors were assessed.

RESULTS

Among 6663 patients, 197 had PTX/PM (3 %) (75 PM, 40 PTX, 82 both). The median age was 59, with 71 % males. Exposure to invasive and non-invasive mechanical ventilation and high-flow nasal cannula before PTX/PM were 42 %, 17 %, and 20 %, respectively. Among isolated PTX and PM/PTX patients 70 % and 53.7 % underwent an intervention, respectively, while 96 % of the PM-only group was followed conservatively.A total of 171 patients with PTX/PM were compared to 171 matched controls. PTX/PM patients had more underlying lung disease (40.9 vs. 23.4 %, p < 0.001) and lower median body mass index (BMI) (29.5 vs. 31.3 kg/m2, p = .007) than controls. Among patients with available data, PTX/PM patients had higher median positive end-expiratory and plateau pressures than controls; however, differences were not significant (10 vs. 8 cmH2O; p = 0.38 and 28 vs. 22 cmH2O; p = 0.11, respectively). PTX/PM patients had a higher odds of mortality (adjusted odds ratio [95%CI]: 3.37 [1.61-7.07]) and longer mean LOS (percent change [95%CI]: 39 [9-77]) than controls.

CONCLUSION

In COVID-19 patients with similar severity, PTX/PM patients had more underlying lung disease and lower BMI. They had significantly increased mortality and LOS.

Для цитирования: Tekin Aysun, Devarajan Anusha, Sakata Kenneth K, Qamar Shahraz, Sharma Mayank, Valencia Morales Diana J, Malinchoc Michael, Talaei Fahimeh, Welle Stephanie, Taji Jamil, Khosa Sandeep, Sharma Nikhil, Brown Meghan, Lal Amos, Bansal Vikas, Khan Syed Anjum, La Nou Abigail T, Sanghavi Devang, Cartin-Ceba Rodrigo, Kashyap Rahul, Gajic Ognjen, Domecq Juan P, Azadeh Natalya. Pneumomediastinum and pneumothorax in coronavirus disease-2019: Description of a case series and a matched cohort study.. Heliyon. 2024. DOI: 10.1016/j.heliyon.2024.e33679.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.